Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications.

biomarkers cell-free DNA circulating tumor DNA liquid biopsy precision oncology

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
10 Jul 2021
Historique:
received: 19 05 2021
revised: 01 07 2021
accepted: 06 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 25 7 2021
Statut: epublish

Résumé

Current approaches for cancer detection and characterization are based on radiological procedures coupled with tissue biopsies, despite relevant limitations in terms of overall accuracy and feasibility, including relevant patients' discomfort. Liquid biopsies enable the minimally invasive collection and analysis of circulating biomarkers released from cancer cells and stroma, representing therefore a promising candidate for the substitution or integration in the current standard of care. Despite the potential, the current clinical applications of liquid biopsies are limited to a few specific purposes. The lack of standardized procedures for the pre-analytical management of body fluids samples and the detection of circulating biomarkers is one of the main factors impacting the effective advancement in the applicability of liquid biopsies to clinical practice. The aim of this work, besides depicting current methods for samples collection, storage, quality check and biomarker extraction, is to review the current techniques aimed at analyzing one of the main circulating biomarkers assessed through liquid biopsy, namely cell-free nucleic acids, with particular regard to circulating tumor DNA (ctDNA). ctDNA current and potential applications are reviewed as well.

Identifiants

pubmed: 34298675
pii: cancers13143460
doi: 10.3390/cancers13143460
pmc: PMC8307284
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

NPJ Precis Oncol. 2020 Feb 24;4:3
pubmed: 32133418
Curr Pathobiol Rep. 2018;6(4):275-286
pubmed: 30595972
PLoS One. 2014 Apr 03;9(4):e93933
pubmed: 24699908
Nat Rev Cancer. 2011 Sep 23;11(10):726-34
pubmed: 21941284
Cancer Genet. 2018 Dec;228-229:143-150
pubmed: 29567030
Ann N Y Acad Sci. 2006 Sep;1075:313-7
pubmed: 17108226
Clin Cancer Res. 2018 Dec 15;24(24):6248-6256
pubmed: 30348637
Epigenetics. 2021 Jun-Jul;16(7):797-807
pubmed: 33074045
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
J Thromb Haemost. 2012 Mar;10(3):437-46
pubmed: 22212198
Biochim Biophys Acta. 2016 Jan;1859(1):3-15
pubmed: 26477492
Theranostics. 2020 Mar 15;10(10):4544-4556
pubmed: 32292514
Clin Cancer Res. 2019 Dec 1;25(23):7035-7045
pubmed: 31383735
Sci Rep. 2019 Jan 14;9(1):114
pubmed: 30643180
Thorac Cancer. 2019 Oct;10(10):1973-1983
pubmed: 31441578
JAMA Oncol. 2019 May 1;5(5):696-702
pubmed: 30816954
J Exp Clin Cancer Res. 2018 Mar 27;37(1):68
pubmed: 29587818
Yonsei Med J. 2012 Jan;53(1):132-7
pubmed: 22187243
PLoS One. 2018 Mar 16;13(3):e0194630
pubmed: 29547634
Gigascience. 2016 Aug 02;5(1):34
pubmed: 27485345
Clin Chem. 2020 Jan 1;66(1):149-160
pubmed: 31628139
Clin Cancer Res. 2017 Oct 1;23(19):5729-5736
pubmed: 28972084
Mol Cancer. 2017 Apr 14;16(1):80
pubmed: 28410618
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
J Mol Diagn. 2016 Jan;18(1):15-22
pubmed: 26586227
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7361-6
pubmed: 24799715
Theranostics. 2020 Jan 16;10(5):2374-2384
pubmed: 32089746
Biotechniques. 2018 May;64(5):225-230
pubmed: 29793362
Mol Oncol. 2017 Mar;11(3):295-304
pubmed: 28164427
Cancers (Basel). 2019 Nov 28;11(12):
pubmed: 31795152
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4858-4863
pubmed: 32075918
Transl Lung Cancer Res. 2016 Dec;5(6):665-672
pubmed: 28149760
PLoS One. 2020 Sep 25;15(9):e0237802
pubmed: 32976510
Nature. 2013 May 2;497(7447):108-12
pubmed: 23563269
Nat Biotechnol. 2019 Apr;37(4):424-429
pubmed: 30804537
Tumour Biol. 2020 Apr;42(4):1010428320916314
pubmed: 32338581
Nat Genet. 2005 Aug;37(8):853-62
pubmed: 16007088
Angew Chem Int Ed Engl. 2011 Mar 1;50(10):2289-93
pubmed: 21351338
PLoS One. 2018 Dec 6;13(12):e0208508
pubmed: 30521613
Gene. 2016 Sep 15;590(1):142-8
pubmed: 27317895
Oncotarget. 2014 Jun 15;5(11):3607-10
pubmed: 25003820
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5
pubmed: 21586637
Transl Oncol. 2015 Oct;8(5):407-416
pubmed: 26500031
Genome Med. 2020 Jun 24;12(1):54
pubmed: 32580754
Nucleic Acids Res. 2000 Apr 15;28(8):E32
pubmed: 10734209
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
ACS Sens. 2018 Mar 23;3(3):540-560
pubmed: 29441780
J Clin Lab Anal. 2019 Feb;33(2):e22668
pubmed: 30175467
J Mol Diagn. 2016 Jan;18(1):23-31
pubmed: 26596526
J Mol Biol. 2019 Sep 5;:
pubmed: 31493411
Cancer Med. 2020 Sep;9(18):6463-6472
pubmed: 32697890
Methods Mol Biol. 2019;1956:383-435
pubmed: 30779047
JAMA Oncol. 2019 Dec 1;5(12):1710-1717
pubmed: 31621801
Nat Med. 2020 Jul;26(7):1044-1047
pubmed: 32572265
PLoS One. 2015 Oct 16;10(10):e0140712
pubmed: 26474073
Nat Methods. 2017 Apr;14(4):411-413
pubmed: 28218897
Sci Transl Med. 2018 Nov 7;10(466):
pubmed: 30404863
Nat Rev Clin Oncol. 2018 Sep;15(9):541-563
pubmed: 29784926
J Cell Mol Med. 2015 Oct;19(10):2307-23
pubmed: 26119132
J Clin Microbiol. 2019 Oct 23;57(11):
pubmed: 31511335
Epigenetics Chromatin. 2017 Apr 20;10:16
pubmed: 28428825
Life Sci. 2020 May 1;248:117473
pubmed: 32114007
PLoS One. 2012;7(7):e41162
pubmed: 22815955
J Natl Cancer Inst. 2005 Dec 21;97(24):1848-50
pubmed: 16368947
J Clin Oncol. 2018 Jun 1;36(16):1631-1641
pubmed: 29504847
Clin Epigenetics. 2020 Jun 22;12(1):90
pubmed: 32571390
JAMA Oncol. 2020 Sep 1;6(9):1410-1415
pubmed: 32644110
Cell. 2017 Feb 9;168(4):571-574
pubmed: 28187279
PLoS One. 2018 Apr 9;13(4):e0195272
pubmed: 29630678
Biomolecules. 2020 Dec 15;10(12):
pubmed: 33334040
Nat Protoc. 2019 Oct;14(10):2749-2780
pubmed: 31471598
Cancer Genet. 2018 Dec;228-229:21-27
pubmed: 30553469
Genome Biol. 2018 Mar 15;19(1):33
pubmed: 29544553
Acta Histochem. 2014 Jan;116(1):55-60
pubmed: 23810682
Nature. 2019 Jun;570(7761):385-389
pubmed: 31142840
EBioMedicine. 2018 Jun;32:111-118
pubmed: 29807833
Metabolites. 2018 Dec 04;8(4):
pubmed: 30518126
Cancer Lett. 2017 Sep 28;404:62-69
pubmed: 28687355
Int J Cancer. 2020 Sep 15;147(6):1740-1752
pubmed: 32191343
Clin Chim Acta. 2015 Oct 23;450:243-53
pubmed: 26341895
Nat Med. 2014 May;20(5):548-54
pubmed: 24705333
Ann Oncol. 2020 Jun;31(6):745-759
pubmed: 33506766
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):399-406
pubmed: 26604269
PLoS One. 2019 Apr 4;14(4):e0214368
pubmed: 30946758
Clin Transl Oncol. 2020 Jun;22(6):823-834
pubmed: 31559582
Comput Struct Biotechnol J. 2018 Oct 09;16:370-378
pubmed: 30364656
J Mol Diagn. 2020 Aug;22(8):1070-1086
pubmed: 32497717
Ann Oncol. 2015 Aug;26(8):1715-22
pubmed: 25851626
World J Clin Oncol. 2018 Apr 10;9(2):26-32
pubmed: 29651384
Nucleic Acids Res. 2016 Feb 18;44(3):e22
pubmed: 26384417
JAMA Oncol. 2019 Oct 1;5(10):1473-1478
pubmed: 31369045
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14508-13
pubmed: 22853953
Clin Chem. 2015 Jan;61(1):202-12
pubmed: 25361949
J Vis Exp. 2018 Apr 5;(134):
pubmed: 29683453
Ann Oncol. 2017 Jun 1;28(6):1325-1332
pubmed: 28419195
Comput Struct Biotechnol J. 2018 Jun 01;16:190-195
pubmed: 29977481
Expert Rev Mol Diagn. 2018 Feb;18(2):133-145
pubmed: 29307231
Clin Cancer Res. 2019 May 15;25(10):3046-3053
pubmed: 30808777
Expert Rev Mol Diagn. 2021 Mar;21(3):299-310
pubmed: 33683971
J Mol Diagn. 2017 Jan;19(1):162-168
pubmed: 27865784
Int J Mol Sci. 2019 Feb 06;20(3):
pubmed: 30736351
EBioMedicine. 2020 Dec;62:103103
pubmed: 33161228
Clin Biochem. 2012 Nov;45(16-17):1497-502
pubmed: 22820431
J Cell Mol Med. 2014 Mar;18(3):371-90
pubmed: 24533657
Ann Oncol. 2018 Dec 1;29(12):2348-2355
pubmed: 30346475
Cancers (Basel). 2019 Jun 11;11(6):
pubmed: 31212602
J Mol Diagn. 2019 Nov;21(6):1067-1078
pubmed: 31442674
Nat Commun. 2020 Jan 21;11(1):400
pubmed: 31964864
Lab Chip. 2018 Apr 17;18(8):1174-1196
pubmed: 29569666
Clin Cancer Res. 2017 May 15;23(10):2471-2477
pubmed: 27827317
Mol Oncol. 2021 Jan;15(1):57-66
pubmed: 33070443
Nat Med. 1996 Sep;2(9):1035-7
pubmed: 8782464
Clin Chim Acta. 2013 Sep 23;424:222-30
pubmed: 23727028
Clin Chim Acta. 2017 Jun;469:94-98
pubmed: 28373054
Mol Oncol. 2019 Feb;13(2):392-402
pubmed: 30516338
Epigenetics. 2007 Apr-Jun;2(2):86-91
pubmed: 17965602
J Breast Cancer. 2017 Mar;20(1):12-19
pubmed: 28382090
Cell Res. 2017 Oct;27(10):1231-1242
pubmed: 28820176
Clin Cancer Res. 2021 Feb 1;27(3):799-806
pubmed: 33172896
Ann Oncol. 2019 Oct 1;30(10):1580-1590
pubmed: 31373349
Nat Rev Clin Oncol. 2021 May;18(5):297-312
pubmed: 33473219
Nat Biotechnol. 2008 Jul;26(7):779-85
pubmed: 18612301
Nat Med. 2020 Jul;26(7):1041-1043
pubmed: 32572266
Int J Mol Sci. 2013 Jul 18;14(7):15029-58
pubmed: 23873296
JCO Precis Oncol. 2019 Oct 3;3:
pubmed: 33015522
Int J Cancer. 2020 Mar 1;146(5):1359-1368
pubmed: 31241775
PLoS One. 2020 Apr 10;15(4):e0229976
pubmed: 32275679
J Mol Diagn. 2017 Sep;19(5):801-804
pubmed: 28732213
Nat Rev Cancer. 2017 Apr;17(4):223-238
pubmed: 28233803
Nat Commun. 2018 Nov 29;9(1):5068
pubmed: 30498206
Clin Biochem. 2015 Oct;48(15):993-8
pubmed: 26234639
Eur J Dent. 2017 Jul-Sep;11(3):385-389
pubmed: 28932152
Cancers (Basel). 2020 May 13;12(5):
pubmed: 32414097
Nat Rev Clin Oncol. 2018 Sep;15(9):577-586
pubmed: 29968853
Sci Rep. 2019 Sep 2;9(1):12620
pubmed: 31477768
Nat Protoc. 2017 Apr;12(4):664-682
pubmed: 28253235
Nat Commun. 2020 Jul 21;11(1):3475
pubmed: 32694610
J Thorac Oncol. 2019 May;14(5):816-824
pubmed: 30664990
Ann Oncol. 2021 Feb;32(2):229-239
pubmed: 33232761
Nature. 2018 Nov;563(7732):579-583
pubmed: 30429608
Heliyon. 2018 Jul 25;4(7):e00699
pubmed: 30094369
Int J Mol Sci. 2017 Jan 29;18(2):
pubmed: 28146051
Cancers (Basel). 2020 Oct 24;12(11):
pubmed: 33114393
Biomedicines. 2020 Dec 25;9(1):
pubmed: 33375577
Curr Protoc Mol Biol. 2010 Jul;Chapter 7:Unit 7.9.1-17
pubmed: 20583099
Methods Mol Biol. 2017;1492:95-106
pubmed: 27822858
Sci Rep. 2019 Nov 19;9(1):17052
pubmed: 31745186
Genome Biol. 2014;15(11):517
pubmed: 25406369
Epigenomics. 2009 Dec;1(2):331-45
pubmed: 20526417
Mol Cancer Res. 2016 Oct;14(10):898-908
pubmed: 27422709
Transl Lung Cancer Res. 2020 Oct;9(5):1873-1884
pubmed: 33209609
PLoS One. 2016 Nov 22;11(11):e0167009
pubmed: 27875576
Clin Chem. 2015 Jun;61(6):838-49
pubmed: 25896989
Br J Cancer. 2021 Jan;124(2):345-358
pubmed: 32968207
Sci Rep. 2016 Feb 12;6:20913
pubmed: 26867973
Front Oncol. 2020 Dec 14;10:596191
pubmed: 33381456
Biomol Detect Quantif. 2019 Feb 13;17:100078
pubmed: 30906693
Am J Cancer Res. 2015 Jun 15;5(7):2258-65
pubmed: 26328256
PLoS One. 2019 Oct 3;14(10):e0223112
pubmed: 31581267

Auteurs

Gabriella Cirmena (G)

Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.

Martina Dameri (M)

Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.

Francesco Ravera (F)

Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.

Piero Fregatti (P)

U.O.C. Clinica di Chirurgia Senologica, Department of Surgery, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Alberto Ballestrero (A)

Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.
U.O.C. Clinica di Chirurgia Senologica, Department of Surgery, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Gabriele Zoppoli (G)

Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.
U.O.C. Clinica di Chirurgia Senologica, Department of Surgery, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Classifications MeSH